Clinical Trials
2 trialsNCT04021108 2025-06-24
Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
Weill Medical College of Cornell University
Phase 2 Active not recruiting
NCT00073502 2006-02-22
Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer
OSI Pharmaceuticals
Phase 2 Completed